Rapidly growing pancreatic ductal adenocarcinoma in a patient with metastatic melanoma and harbouring CDKN2A germline mutation: a new vemurafenib-induced malignancy?

Melanoma Res. 2013 Jun;23(3):241. doi: 10.1097/CMR.0b013e32836124aa.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Carcinoma, Pancreatic Ductal / chemically induced*
  • Carcinoma, Pancreatic Ductal / genetics
  • Carcinoma, Pancreatic Ductal / pathology
  • Genes, p16*
  • Germ-Line Mutation*
  • Humans
  • Indoles / adverse effects*
  • Male
  • Melanoma / genetics*
  • Melanoma / pathology
  • Neoplasm Metastasis
  • Pancreatic Neoplasms / chemically induced*
  • Pancreatic Neoplasms / genetics
  • Pancreatic Neoplasms / pathology
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / pathology
  • Sulfonamides / adverse effects*
  • Vemurafenib

Substances

  • Indoles
  • Sulfonamides
  • Vemurafenib